Enclosed herewith results presentation for the period ended June 30, 2026.

August 13, 2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400 001. Dear Sir/Madam, Sub: Results Presentation for the period ended June 30, 2026 Ref: Dai‐ichi Karkaria Limited (Scrip Code 526821) Please find enclosed herewith the Results Presentation of the Company for the period ended June 30, 2026, for your records and the same will be placed on the website of the Company i.e. http://www.dai‐ ichiindia.com/investors For DAI‐ICHI KARKARIA LIMITED Ankit Shah Company Secretary and Compliance officer Encl: as above DAI-ICHI KARKARIA LIMITED Registered Office: Liberty Building, 3rd & 4th Floor, Sir Vithaldas Thackersey Marg, Mumbai 400020, India. T: +91 22 69117130 Factory: Plot No. D-2/20, GIDC, Industrial Estate, Dahej-2, Taluka Vagra, Bharuch, Gujarat 392130, India. T: +91 261 6723500 Factory: Plot No. D-13, MIDC, Kurkumbh, Dist: Pune 413802, India. T: +91 2117 235261/62 CIN: L24100MH1960PLC011681 E: info@dai-ichiindia.com W: www.dai-ichiindia.com FY2023-24 Q1 FY26-27 COMPANY PRESENTATION ABOUT US Dai-ichi India commenced production in 1963, in technical collaboration with Dai-ichi Kogyo Seiyaku based in Japan. We develop and manufacture high- performance speciality chemicals for various industrial applications. We market innovative products, providing custom solutions tailored to our client’s needs. Sustainability and innovation are key factors in all our business operations. OUR STRENGTHS Research & Development Quality Control Innovation We work towards creating products and Our batch-to-batch consistencies are We work with a focus on product design, processes that are clean, reflecting the maintained by rigorous, regular and complete process efficiency and environmental health & integrity of our manufacturing process, with testing at every stage. safety. minimum use of hazardous chemicals and We conform to all relevant health, safety, By integrating new technologies and efficient chemical synthesis. environmental, national, and international sustainable practices, we aim to reduce our Customers have partnered with us to resolve standards. environmental impact while enhancing product specific performance issues, challenging our performance. R&D team to find a cost effective solution. OUR MILESTONES 1963 1967 1980 1981 1991 1995 Commenced Developed the first Developed the Technical Established a JV Dai-ichi Karkaria India production in Pimpri, demulsifier in India first PPD in India collaboration with with Baker listed on BSE; Invested Pune, in technical for ONGC Matsumoto Yushi- Petrolite for the in flocculants plant in collaboration with Seiyaku of Japan for manufacture of oil Kurkumbh; Set up a Dai-ichi Kogyo sizing agents & Spin field chemicals pharmaceutical facility in Seiyaku of Japan Finishes Hyderabad, concluded in 2015 2005 2008 2009 2018 2022 2026 JV is created for Acquired 40% stake of Formed a JV with Champion Commissioning of our Oilfield plant Ethoxylation capacity pharma products with Baker Production Technologies (now new plant in Dahej, commissioned expansion; Inogent, in Services (UK), making it ChampionX), specifically for for the manufacture December 2022 with commissioned new collaboration with a wholly owned the Indian oil eld upstream of Alkoxylates and enhanced capacities oilfield reactors to GVK Biosciences subsidiary of Dai-ichi chemical sector Oilfield chemicals modernise production line. MANUFACTURING CAPABILITIES Ethoxylation Sulfosuccination Propoxylation Sulfation Reactions Esterification / Transesterification Phosphorylation Polymerisation Quarternisation INDUSTRIES CATERED TO Construction Home & Oilfield Paints, Pigments Agrochemicals Chemicals Personal Care Chemicals & Coatings Textile Flocculants for Rayon Additives Sizing Water & Chemicals Auxiliaries Paper, Sugar & Environment Mining Industry Q1 FY26-27 RESULTS MANAGEMENT NOTE We are pleased to share that the Company has delivered a strong start to FY 2026‐27, with revenue of Rs. 57.84 crore in Q1, representing a growth of approximately 47% over the corresponding quarter of the previous year and 40% over the preceding quarter, and ahead of our planned budget for the period. This performance reflects the strength of our diversified business portfolio. Oilfield Chemicals remained our largest business segment, contributing over half of quarterly revenue, supported by healthy upstream demand across select international markets. While certain downstream product categories were affected by geopolitical developments in the Middle East impacting customer procurement and project timelines, the segment continued to demonstrate resilience and remains a significant growth driver for the Company. Our Home & Personal Care segment recorded strong growth during the quarter, supported by a growing customer relationship with increased export demand and ongoing new product development. Agrochemicals continued its seasonal recovery, with customer sampling and application development activity progressing well through our internal application laboratory. Paints & Coatings and Textiles saw softer demand during the quarter on account of macroeconomic and input cost pressures, though early signs of improvement are visible as we enter the second quarter. On the manufacturing front, we successfully commissioned an additional ethylene oxide reactor at our Dahej facility during the quarter, strengthening our production capabilities and flexibility to serve customers across ethoxylated product categories. Commercialising this expanded capacity, alongside the additional oilfield production capacity added during the quarter, will be a key priority through the remainder of FY 2026‐27. We remain focused on commercialising our expanded capacities, deepening customer relationships across our segments, and driving sustainable, profitable growth for our shareholders, while continuing to prioritise the safety, sustainability and operational excellence that underpin our long term strategy. STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDING 30/06/26 DISCLAIMER Dai-ichi Karkaria Limited may, from time to time, make written and oral forward looking statements, in addition to statements contained in the company's filings with BSE Limited and our reports to shareholders. The company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Dai-ichi Karkaria Limited. All information contained in this presentation may be forward-looking statements that involve risks and uncertainties. The Company undertakes no obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events, or otherwise. Actual results, performances or achievements could differ materially from those expressed or implied in such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements. This presentation should be read in conjunction with the financial statements issued from time to time.